Effects of ΟΝΟ-1101, a novel β-adrenoceptot antagonist, on action potential and membrane currents in cardiac myocytes

Muraki, Katsuhiko; Nakagawa, Hidehiko; lmagano, K.; Henmi, Satoshi; Kawasumi, Hisashi; Nakanishi, Takumi; lmaizumi, Katsumi; Tokuno, Tomoaki; Atsuki, Kaoru; Imaizumi, Yuji; Watanabe, Minoru

doi:10.1016/s0021-5198(19)46483-4

Japanese Journal of Pharmacology

1995

DOI: 10.1016/s0021-5198(19)46483-4

|View full text |Cite

Effects of ΟΝΟ-1101, a novel β-adrenoceptot antagonist, on action potential and membrane currents in cardiac myocytes

Katsuhiko Muraki

Hidehiko Nakagawa

K. lmagano

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2009

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, esmolol occasionally induces excessive negative chronotropic and inotropic actions [12][13][14] . In this context, the recently developed, selective short-acting ß1-antagonist, landiolol, has been reported to have a lesser effect on blood pressure compared to esmolol in animal models and in a clinical trial [15][16][17] . However, no consensus has been reached regarding the optimum dose or the mode and timing of delivery.…”

mentioning

confidence: 99%

The Efficacy of Landiolol for Suppressing the Hyperdynamic Response following Laryngoscopy and Tracheal Intubation: A Systematic Review

Inoue

Tanaka

Kawaguchi

et al. 2009

Anaesth Intensive Care

View full text Add to dashboard Cite

Landiolol is a recently developed, selective short-acting ß1-antagonist. The aim of the study was to evaluate the efficacy of landiolol for suppressing haemodynamic changes induced by laryngoscopy and tracheal intubation (LTI) in Japanese patients. A comprehensive search was undertaken to identify all randomised comparisons of landiolol with placebo that examined effects on haemodynamic responses following LTI. MEDLINE, Cochrane CENTRAL, EMBASE and the Japanese Central Review of Medicine were searched from their date of inception to February 2009. Trials were included in the review if heart rate, systolic blood pressure or mean blood pressure was recorded at three different stages: pre-induction, just before intubation and in the post-intubation period. Weighted mean differences and 95% confidence intervals (CI) were calculated for changes in haemodynamic variables between treatment and placebo groups. Seven randomised controlled trials involving 325 patients were included in the study. Of these, five trials that used the same continuous infusion regimen for landiolol (0.125 mg/kg/minute for one minute followed by 0.04 mg/kg/minute) showed efficacy in attenuation of heart rate and blood pressure following LTI (heart rate weighted mean difference:-21.18 bpm, 95% CI-18.59 to-14.20; systolic blood pressure weighted mean difference:-23.03 mmHg, 95% CI-43.59 to-2.47; mean blood pressure weighted mean difference:-16.26 mmHg, 95% CI-23.96 to-8.55). The other two studies used bolus administration of landiolol (0.1 to 0.3 mg/kg), but it was difficult to evaluate the efficacy because of the limited amount of data. Landiolol administration at 0.125 mg/kg/minute for one minute followed by 0.04 mg/kg/minute effectively suppresses the increases in heart rate and blood pressure following LTI. For a bolus regimen of landiolol, further studies are required to determine the efficacy and the optimal dose and timing for suppression of haemodynamic responses following LTI.

show abstract

mentioning

confidence: 99%

The Efficacy of Landiolol for Suppressing the Hyperdynamic Response following Laryngoscopy and Tracheal Intubation: A Systematic Review

Inoue

Tanaka

Kawaguchi

et al. 2009

Anaesth Intensive Care

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Effects of ΟΝΟ-1101, a novel β-adrenoceptot antagonist, on action potential and membrane currents in cardiac myocytes

Cited by 1 publication

References 0 publications

The Efficacy of Landiolol for Suppressing the Hyperdynamic Response following Laryngoscopy and Tracheal Intubation: A Systematic Review

The Efficacy of Landiolol for Suppressing the Hyperdynamic Response following Laryngoscopy and Tracheal Intubation: A Systematic Review

Contact Info

Product

Resources

About